Evaluation of aspirin and clopidogrel resistance in patients with acute coronary syndrome by using adenosine diposphate test and aspirin test

Pakistan Journal of Medical Sciences

Volumn 29, Issue 1, 2013, Pages

  Ibrahim, O ^a   Oteh, M ^a   A, Syukur A ^a   Che Hassan, H H ^a   Fadilah W, S ^a   Rahman, Mm ^a  

^a DEPARTMENT OF PHARMACOLOGY   (Malaysia)

Author keywords

Acute coronary syndromes; Anti platelet therapy; Aspirin; Clopidogrel; Hyperlipidaemia

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM; CLOPIDOGREL; TRIACYLGLYCEROL;

ACUTE CORONARY SYNDROME; ADENOSINE DIPHOSPHATE TEST; ADULT; AGGREGOMETER; ANALYZER; ARTICLE; ASPIRIN TEST; CALCIUM BLOOD LEVEL; COMORBIDITY; CROSS-SECTIONAL STUDY; DRUG RESPONSE; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PREVALENCE; THROMBOCYTE AGGREGATION INHIBITION;

EID: 84868377276     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Anti-thrombotic Trialist's Collaboration (ATTC). Collaborative meta-analysis of randomised trials of anti-platelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324(7329):71-86.
2. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in 45, 852 patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345(7):494-502.
3. Chen ZM, Jiang LX, Chen YP, Xie JX, Pan HC, Peto R, et al. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarctions: randomised placebo-controlled trial. Lancet. 2005;366(9497):1607-1621.
4. Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. NEJM. 2006;354(16):1706-1717.
5. Sabatine MS, Cannon CP, Gibson CM, López-Sendón JL, Montalescot G, Theroux P, et al. Addition of clopidogrel to aspirin and fbrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005;352(12):1179-1189.
6. Gurbel PA, Bliden KP, DiChiara J, Newcomer J, Weng W, Neerchal NK, et al. Evaluation of dose-related effects of aspirin on platelet function. Results from the aspirin-induced platelet effect (ASPECT) study. Circulation. 2007;115(25):3156-3164.
7. Von Pape KW, Dzijan-Horn M, Bohner J, Spannagl M, Weisser H, Calatzis A. Control of aspirin effect in chronic cardiovascular patients using two whole blood platelet function assays. PFA-100 and Multiplate. Hamostaseologie. 2007;27(3):155-160.
8. Rahe-Meyer N, Winterhalter M, Hartmann J, Pattison A, Hecker H, Calatzis A, et al. An evaluation of cyclooxygenase-1 inhibition before coronary artery surgery: aggregometry versus patient self-reporting. Anesth Analg. 2008;107(6):1791-1797.
9. Jambor C, Weber CF, Lau A, Spannagl M, Zwissler B. Multiple electrode aggregometry for ex-vivo detection of the anti-platelet effect of non-opioid analgesic drugs. Thromb Haemost. 2009;101(1):207-209.
10. Sibbing D, Braun S, Jawansky S, Vogt W, Mehilli J, Schömig A, et al. Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment. Thromb Haemost. 2008;99(1):121-126.
11. Velik-Salchner C, Maier S, Innerhofer P, Streif W, Klingler A, Kolbitsch C, et al. Point-of-care whole blood impedance aggregometry versus classical light transmission aggregometry for detecting aspirin and clopidogrel: the results of a pilot study. Anesth Analg. 2008;107(6):1798-1806.
12. Sibbing D, Busch G, Braun S, Jawansky S, Schomig A, Kastrati A, et al. Impact of bivalirudin or unfractionated heparin on platelet aggregation in patients pretreated with 600 mg clopidogrel undergoing elective percutaneous coronary intervention. Eur Heart J. 2008;29(12):1504-1509.
13. Mengistu AM, Rohm KD, Boldt J, Mayer J, Suttner SW, Piper SN. The infuence of aprotinin and tranexamic acid on platelet function and postoperative blood loss in cardiac surgery. Anesth Analg. 2008;107(2):391-397.
14. Boldt J, Wolf M, Mengistu A. A new plasma-adapted hydroxyethylstarch preparation: in vitro coagulation studies using thrombelastography and whole blood aggregometry. Anesth Analg. 2007;104(2):425-430.
15. Scharbert G, Kalb M, Marschalek C, Kozek-Langenecker SA. The effects of test temperature and storage temperature on platelet aggregation: a whole blood in vitro study. Anesth Analg. 2006;102(4):1280-1284.
16. Geisler T, Langer H, Wydymus M, Gohring K, Zurn C, Bigalke B, et al. Low response to clopidogrel is associated with cardiovascular outcome coronary stent implantion. Eur Heart J. 2006;27(20):2420-2425.
17. Abaci A, Caliskan M, Bayram F, Yilmaz Y, Cetin M, Unal A, et al. A New defnition of aspirin non-responsiveness by Platelet Function Analyzer-100TM and its predictors. Platelets. 2006;17(1):7-13.
18. Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Escaned J, Moreno R, et al. 807 C/T Polymorphism of the glycoprotein Ia gene and pharmacogenetic modulation of platelet response to dual anti-platelet treatment. Blood Coagul Fibrinolysis. 2004;15(5):427-433.
19. Lee PY, Chen WH, Ng W, Cheng X, Kwok JY, Tse HF, et al. Low-dose aspirin increases aspirin resistance in patients with coronary artery disease. Am J Med 2005;118(7):723-727.
20. Serebruany VL, Malinin A, Ong S, Atar D. Patients with metabolic syndrome exhibit higher platelet activity than those with conventional risk factors for vascular disease. J Thromb Thrombolysis. 2008;25(2):207-213.
21. Watala C, Golanski J, Pluta J, Boncler M, Rozalski M, Luzak B, et al. Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)-its relationto metabolic control. Thromb Res. 2004;113(2):101-113.
22. Saito K, Sano H, Kawahara J, Yokoyama M. Calcium supplementation attenuates an enhanced platelet function in salt-loaded mildly hypertensive Patients. Hypetension. 1995;26(1):156-163.
23. Ho PM, Maddox TM, Wang L, Fihn SD, Jesse RL, Peterson ED, et al. Risk of Adverse Outcomes Associated With Concomittant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Sydrome. JAMA. 2009;301(9):937-944.
24. Serebruany VL, Malinin A, Atar D, Hanley DF. Consistent platelet inhibition during long-term maintenance-dose clopidogrel therapy among 359 compliant outpatients with documented vascular disease. Am Heart J. 2007;153(3):371-377.